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sample is small, the propensity of low thiamine in female pa-
tients is intriguing and merits follow up.
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Background: Patients can develop poor appetite, mucositis
and gastrointestinal failure leading to malnutrition after he-
matopoietic stem cells transplant (HSCT). It has been reported
that the sufficient nutrition strategies are related to de-
crease of infectious disease or acute GVHD. Therefore, the
nutritional management throughout all transplant period is
important. In general, two-fold higher protein than basic level
is required for tissue repair as well as for preventing col-
lapse of the fat free mass in patients. Based on this, 1.5g/
kg·BW of protein are recommended in adult patients with
cancer on The Clinical Guide to Oncology Nutrition.
However, there are only few previous reports about HSCT pa-
tients especially in Japan. In this study, we studied the protein
sufficiency rate and the heat capacity / nitrogen ratio (non-
protein calorie/nitrogen: NPC/N) as outcomes of nutritional
management and analyzed the relationship between these
factors and hospital length of stay.
Methods: This study enrolled 16 adult patients who re-
ceived HSCT at Okayama University Hospital from Jun.2016
to Jan. 2017 and discharged before day 100 after transplant.
We retrospectively collected data for percentage of body
weight loss (%LBW), protein sufficiency rate, NPC/N, and blood
chemistry data about nutritional status. Also, we compared
these parameters between two groups that are defined by du-
ration from start of preparative regimen to discharge. Group
1 (short-term group) includes patients with less than 50 days
of stay and Group 2 (long-term group) includes patients with
50 days or more of stay.
Results: A tendency of the negative correlation between a
protein sufficiency rate and hospitalization days was seen
(rs = .45 P = .1). Also, duration of hospitalization was
positively correlated to NPC/N (rs = .924 P = .01). In compar-
ison of two groups (group 1 vs group 2), tendency of lower
BW loss rate (−4.31% vs −5.37%), lower NPC/N (130.7 vs
157.3) and higher protein sufficiency (99.9% vs 94.0%) were
found in short-term group, which were not statistically
significant.
Conclusion: Sufficient energy supply from protein might de-
crease hospital length of stay. Further analysis including more
cases is ongoing.
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Background: Hematopoietic Stem Cell Transplantation (HSCT)
in elderly is a brand-new issue. Changes in body composi-
tion after HSCT have been the subject of previous studies,
however there aren’t many studies in elderly people.
Objectives: To evaluate muscle thickness and visceral fat by
US; % muscle mass, % fat mass and phase angle by BIA. To
correlate body composition with engraftment(EN).
Methods: In this prospective study, we evaluated 16 HSCT
patients (≥60years) at Hospital Israelita Albert Einstein, São
Paulo, Brazil, on their first day of hospitalization, before HSCT
and after the EN. The thickness of the right femoral quadri-
ceps muscle (RFQ), measured at 6 cm from the top edge of
the patella was measured using ultrasound (US) in B-mode,
transversal plane. The visceral fat(VF) was measured in the
abdominal region, by the thickness of the fat layer between
the linea alba and the anterior wall of the aorta. The % muscle
mass (MM), % fat mass(FM) and phase angle(PA) were evalu-
ated by Bioimpedanciometry(BIA).
Results: Most patients were men (75%) with a mean age of
64(±5,0 years). We had 50% of autologous HSCT and 50%
allogenic HSCT. The mean time EN was 13(±4 days). In the
baseline, weight was 80(±17 kg), RFQ was 1.8(±.3 cm) and
the VF was 5,5(±2,0 cm); %MM was 68,5(±11); %FM was
27,5(±7,5); PA was 5,3((±0,7). After EN, weight was 73(±13 kg).
RFQ was 1.5(±.3 cm) and the VF was 5,0(±2.2 cm); %MM
was 55,5(±20,5); %FM was 25(±7,0); PA was 7,4(±0,8). There
wasn’t significant difference between baseline and after
engraftment, although all measurements had reduced in
all patients, exception for PA and VF had increased. We
found the negative correlation between engraftment and
RFQ (rp: −0,6), independently of HSCT type by regression.
(rp: −0,6).
Conclusion: In this cohort of patients, muscle thickness and
mass was reduced, and visceral fat and phase angle was in-
creased after engraftment. The higher muscle thickness
correlated faster engraftment.
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Background: Mucositis is a complication find in patients un-
dergoing Hematopoietic Stem Cell Transplantation(HSCT). It
results in painful debilitating inflammation, vomiting, diar-
rhea, sleep disturbances, anorexia, weight loss and a decrease
in quality of life. Several studies have demonstrated zinc serum
levels could associate to mucositis and its degree.
Objective: The aim of this study was to correlate zinc defi-
ciency with mucositis and/or mucositis degree.
Methods: It was a retrospective study, based on medical
records and approved by the institutional ethics commit-
tee. We evaluated 117 patients (≥18 years-old) undergoing
HCST, who had zinc serum level evaluated until 5 first days
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of admission in Hospital Israelita Albert Einstein, São Paulo,
Brazil from January 2015 to April 2017. 59 patients were ex-
cluded who did not have serum zinc levelin this period. None
patient has taken zinc supplementation. We analyzed pres-
ence or absence and degree of mucositis, age (less or more
than 60 years), and the time of neutrophilic grafting, pres-
ence or absence GVHD acute or chronic. Categorical variables
were described, using SPSS version 17 software®, by abso-
lute and relative frequencies and compared between groups
with zinc serum levels normal(60-130 mg/dL) or low(<60 mg/
dL) by means of chi-square, Pearson test, independent sample
t-test and Mann-Whitney test.
Results: We analyzed 30 patients were undergone allo-
genic HSCT, everyone treated myeloablative conditioning. We
found a tendency the elderly population (≥60y) had more de-
ficiency of zinc (P = .072). 93% patients had mucositis. Severe
mucositis (grades 3 and 4) was related to zinc deficiency
(P = .01). 28 patients were undergone autologous HSCT, 80%
with mucositis, 72% had 1 or 2 degree oral mucositis. In these
patients there was no statistical difference between the zinc
deficiency and mucositis. We didn’t find any significant result
in GVHD and neutrophilic grafting in autologous an allo-
genic HSCT.
Conclusion: We found severe mucositis is associated to zinc
deficiency in allogenic HSCT.
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Background: Thoracentesis and or paracentesis via pleural
or peritoneal drains (PD) are often needed in hematopoi-
etic cell transplant (HCT) patients with veno-occlusive disease
(VOD) to relieve intra-abdominal pressure, improve respira-
tory mechanics and renal perfusion. However, these may
increase the risk of infection in immunosuppressed patients.
Methods: A retrospective study of HCT patients who devel-
oped VOD during the study period from January 1995 – May
2017 was conducted to analyze the safety of these procedures.
Results: Thirty-nine (39) HCT patients developed VOD at a
median of 12 days (range 3-29) post-HCT. Median age at trans-
plant was 2 years (range 1 month-17 years). Thirty-six (36,
93%) patients received myeloablative conditioning, includ-
ing 25 with busulfan-based conditioning. Peritoneal drain (PD)
was placed in 22 (56%) patients, including 11 HCT recipi-
ents with severe VOD, at a median of 3 days (range 0-31) from
the day of VOD diagnosis. Seven (18%) patients also had a
chest tube (CT) placed at a median of 12.5 days (range 7-33)
from VOD diagnosis. Ten (26%) patients were neutropenic at
the time of PD or CT placement. Hypoxia or tense ascites were
common indications for PD placement. Drains were placed
by interventional radiologists (n = 12) or intensivists (n = 10).
Five of the 22 (23%) patients developed hypotension requir-
ing fluid resuscitation. Seven (32%) patients with PD
experienced drain obstruction requiring intervention, 6 (86%)
were replaced. Obstruction and dislodgement (one each) were
encountered with CTs. Median duration of PDs and CTs were
17 (range 4-55) and 6 (range 0-12) days, respectively. Two
cases of peritonitis due to gram-negative rods (by gram stain
only) occurred and both responded to treatment. Overall mor-
tality was 46% (18/39 patients), but no deaths were directly
attributed to drain placement.
Conclusion: Paracentesis and thoracentesis with drain place-
ment were found to be safe in most patients who developed
VOD.
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Background: Therapeutic paracentesis with peritoneal drain
placement (PD) is often used in the management of hepatic
veno-occlusive disease (VOD) in hematopoietic stem cell
transplant (HCT) recipients. We hypothesized that PD place-
ment would lead to improved outcomes, including respiratory
and renal functions post-VOD.
Methods: We retrospectively studied a cohort of 39 HCT re-
cipients with VOD (study period January 1995 to May 2017)
and compared defined outcomes in groups stratified by timing
and placement of PD.
Results: Twenty-two (22, 56.4%) patients had a PD placed in-
cluding 11 with severe VOD. In comparison to patients
without a PD (n = 17), patients with PD (n = 22) had similar
frequency (65% vs. 91% P = .06) and duration of respiratory
support (median 16 vs. 9 days, P = .88). Renal outcomes were
comparable between both groups as evidenced by the inci-
dence of acute kidney injury (76.4% vs. 86.3%, P = .68); median
time for normalization of age-specific creatinine (16 vs. 10
days, P = .06); and need for dialysis (41.2% vs 18.2% P = .16).
Both groups had a similar incidence of intensive care admis-
sion (58.8% vs 86.4%, P = .07) and equal ICU length of stay (LOS)
(median 10 vs. 19 days, P = .07). Interestingly, patients with
PD had a significantly longer hospital LOS (median 41 vs. 60
days, P < .001). In a subgroup analysis of patients with PD,
there was no difference in the above defined outcomes
between patients who had early PD placement (≤2 days,
n = 10) compared to those who had a later PD placement (>2
days, n = 12).
Conclusion: Although PD placement is associated with symp-
tomatic relief from tense ascites and improves respiratory
mechanics, we did not see a significant difference in pa-
tients who had a PD placed compared to those who did not.
Additionally, timing of PD placement from VOD did not in-
fluence the outcomes.
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